A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women

Journal of the National Cancer Institute

Volumn 107, Issue 10, 2015, Pages

  Murphy, Neil ^a   Strickler, Howard D ^b   Stanczyk, Frank Z ^c   Xue, Xiaonan ^b   Wassertheil Smoller, Sylvia ^b   Rohan, Thomas E ^b   Ho, Gloria Y F ^b   Anderson, Garnet L ^d   Potter, John D ^d,e   Gunter, Marc J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; C REACTIVE PROTEIN; INSULIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ETHNICITY; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; DIET RESTRICTION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESTRADIOL; ESTRONE; FASTING; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; POSTMENOPAUSE; PROGESTERONE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; UNITED STATES;

EID: 84944681655     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv210     Document Type: Article

References (27)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst. 1980;65(6):1201-1207.
3. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst. 1983;71(4):703-709.
4. Nanda K, Bastian LA FAU, Hasselblad VF, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol. 1999;93(5 Pt 2):880-888.
5. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 1999;106(5):574-582.
6. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev. 1998;7(8):653-659.
7. Johnson JR, Lacey JV, Lazovich D, Geller MA, Schairer C, Schatzkin A et al. Menopausal Hormone Therapy and Risk of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(1):196-203.
8. Simon MS, Chlebowski RT, Wactawski-Wende J, et al. Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality. J Clin Oncol. 2012;30(32):3983-3990.
9. Green J, Czanner G, Reeves G, et al. Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis. Int J Cancer. 2012;130(10):2387-2396.
10. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women. N Engl J Med. 2004;350(10):991-1004.
11. Gunter MJ, Hoover DR, Yu H, et al. Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal Women. Cancer Res. 2008;68(1):329-337.
12. Clendenen TV, Koenig KL, Shore RE, Levitz M, Arslan AA, Zeleniuch-Jacquotte A. Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(1):275-281.
13. Lin JH, Zhang SM, Rexrode KM, et al. Association Between Sex Hormones and Colorectal Cancer Risk in Men and Women. Clin Gastroenterol Hepatol. 2013;11(4):419-424.
14. Scott JZ, Stanczyk FZ, Goebelsmann U, Mishell J. A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(o-carboxymethyl) oximino-[125l]-iodo-histamine as radioligand. Steroids. 1978;31(3):393-405.
15. Probst-Hensch NM, Ingles SA, Diep AT, et al. Aromatase and breast cancer susceptibility. Endocrine-Related Cancer. 1999;6(2):165-173.
16. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Controlled Clin Trials. 1998;19(1):61-109.
17. Hays J, Hunt JR, Hubbell FA, et al. The women's health initiative recruitment methods and results. Ann Epidemiol. 2003;13(Suppl 9):S18-S77.
18. Sodergard RF, Backstrom TF, Shanbhag VF, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem. 1982;16(6):801-810.
19. Rinaldi S, Geay A, Dechaud H, et al. Validity of Free Testosterone and Free Estradiol Determinations in Serum Samples from Postmenopausal Women by Theoretical Calculations. Cancer Epidemiol Biomarkers Prev. 2002;11(10):1065-1071.
20. Hartman J, Edvardsson K, Lindberg K, et al. Tumor Repressive Functions of Estrogen Receptor Beta in SW480 Colon Cancer Cells. Cancer Res. 2009;69(15):6100-6106.
21. Waliszewski P, Blaszczyk M, Wolinska-Witort E, Drews M, Snochowski M, Hurst RE. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas. J Surg Oncol. 1997;64(1):3-11.
22. Castiglione F, Taddei AF, Rossi Degl'Innocenti DF, et al. Expression of estrogen receptor beta in colon cancer progression. Diagn Mol Pathol. 2008;17(4):231-236.
23. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7(4):536-540.
24. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutrition. 2007;86(3):556-565.
25. Moghaddam AA, Woodward M, Huxley R. Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533-2547.
26. Terry PD, Miller AB, Rohan TE. Obesity and colorectal cancer risk in women. Gut. 2002;51(2):191-194.
27. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev. 1995;4(6):649-654.